Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Subtotal colectomy and ileorectal anastomosis for slow transit constipation: clinical follow-up at median of 15 years.

Patton V, Balakrishnan V, Pieri C, Doherty P, Phan-Thien KC, King DW, Lubowski DZ.

Tech Coloproctol. 2020 Feb;24(2):173-179. doi: 10.1007/s10151-019-02140-5. Epub 2020 Jan 6.

PMID:
31907721
2.

Relationships between the results of anorectal investigations and symptom severity in patients with faecal incontinence.

Heitmann PT, Rabbitt P, Schloithe A, Patton V, Skuza PP, Wattchow DA, Dinning PG.

Int J Colorectal Dis. 2019 Aug;34(8):1445-1454. doi: 10.1007/s00384-019-03331-0. Epub 2019 Jul 6.

PMID:
31280351
3.

The relationship between residual sphincter damage after primary repair, faecal incontinence, and anal sphincter function in primiparous women with an obstetric anal sphincter injury.

Patton V, Kumar S, Parkin K, Karantanis E, Dinning P.

Neurourol Urodyn. 2019 Jan;38(1):193-199. doi: 10.1002/nau.23826. Epub 2018 Nov 2.

PMID:
30387531
4.

A prospective "bottom up" study of the costs of faecal incontinence in ambulatory patients.

Patton V, Parkin K, Moore KH.

Neurourol Urodyn. 2018 Jun;37(5):1672-1677. doi: 10.1002/nau.23450. Epub 2018 May 14.

PMID:
29756684
5.

Sacral Nerve Stimulation Fails to Offer Long-term Benefit in Patients With Slow-Transit Constipation.

Patton V, Stewart P, Lubowski DZ, Cook IJ, Dinning PG.

Dis Colon Rectum. 2016 Sep;59(9):878-85. doi: 10.1097/DCR.0000000000000653.

PMID:
27505117
6.

Sacral nerve stimulation for faecal incontinence: medium-term follow-up from a single institution.

Patton V, Abraham E, Lubowski DZ.

ANZ J Surg. 2017 Jun;87(6):462-466. doi: 10.1111/ans.13605. Epub 2016 May 19.

PMID:
27193192
7.

Response to Re: Long-term results of the cutting seton for high anal fistula.

Patton V, Lubowski DZ.

ANZ J Surg. 2016 Mar;86(3):209. doi: 10.1111/ans.13401. No abstract available.

PMID:
26940185
8.

Gemcitabine and Chlorotoxin Conjugated Iron Oxide Nanoparticles for Glioblastoma Therapy.

Mu Q, Lin G, Patton VK, Wang K, Press OW, Zhang M.

J Mater Chem B. 2016 Jan 7;4(1):32-36. Epub 2015 Nov 24.

9.

The Authors Reply.

Patton V, Lubowski DZ.

Dis Colon Rectum. 2015 Dec;58(12):e454-5. doi: 10.1097/DCR.0000000000000486. No abstract available.

PMID:
26544822
10.

Long-term results of the cutting seton for high anal fistula.

Patton V, Chen CM, Lubowski D.

ANZ J Surg. 2015 Oct;85(10):720-7. doi: 10.1111/ans.13156. Epub 2015 May 21.

PMID:
25997475
11.

Treatment efficacy of sacral nerve stimulation in slow transit constipation: a two-phase, double-blind randomized controlled crossover study.

Dinning PG, Hunt L, Patton V, Zhang T, Szczesniak M, Gebski V, Jones M, Stewart P, Lubowski DZ, Cook IJ.

Am J Gastroenterol. 2015 May;110(5):733-40. doi: 10.1038/ajg.2015.101. Epub 2015 Apr 21.

PMID:
25895520
12.

Stable and efficient Paclitaxel nanoparticles for targeted glioblastoma therapy.

Mu Q, Jeon M, Hsiao MH, Patton VK, Wang K, Press OW, Zhang M.

Adv Healthc Mater. 2015 Jun 3;4(8):1236-45. doi: 10.1002/adhm.201500034. Epub 2015 Mar 11.

13.

Clinical outcome and efficacy of antegrade colonic enemas administered via an indwelling cecostomy catheter in adults with defecatory disorders.

Patton V, Lubowski DZ.

Dis Colon Rectum. 2015 Apr;58(4):457-62. doi: 10.1097/DCR.0000000000000341.

PMID:
25751803
14.

Colonic motor abnormalities in slow transit constipation defined by high resolution, fibre-optic manometry.

Dinning PG, Wiklendt L, Maslen L, Patton V, Lewis H, Arkwright JW, Wattchow DA, Lubowski DZ, Costa M, Bampton PA.

Neurogastroenterol Motil. 2015 Mar;27(3):379-88. doi: 10.1111/nmo.12502. Epub 2015 Jan 3.

PMID:
25557630
15.

The case for a systematic policy approach to free primary health care for vulnerable groups in New Zealand.

Loh L, Trevallyan S, Main SJ, Revell L, Patton V, Ojo A.

N Z Med J. 2015 Oct 30;128(1424):45-53.

PMID:
27377022
16.

Quantification of in vivo colonic motor patterns in healthy humans before and after a meal revealed by high-resolution fiber-optic manometry.

Dinning PG, Wiklendt L, Maslen L, Gibbins I, Patton V, Arkwright JW, Lubowski DZ, O'Grady G, Bampton PA, Brookes SJ, Costa M.

Neurogastroenterol Motil. 2014 Oct;26(10):1443-57. doi: 10.1111/nmo.12408. Epub 2014 Aug 11.

17.

Risk factors for obstetric anal sphincter injuries and postpartum anal and urinary incontinence: a case-control trial.

Burrell M, Dilgir S, Patton V, Parkin K, Karantanis E.

Int Urogynecol J. 2015 Mar;26(3):383-9. doi: 10.1007/s00192-014-2478-7. Epub 2014 Jul 31.

PMID:
25079296
18.

Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.

Decio A, Taraboletti G, Patton V, Alzani R, Perego P, Fruscio R, Jürgensmeier JM, Giavazzi R, Belotti D.

Am J Pathol. 2014 Apr;184(4):1050-1061. doi: 10.1016/j.ajpath.2013.12.030. Epub 2014 Feb 6. Erratum in: Am J Pathol. 2014 Jul;184(7):2144.

PMID:
24508126
19.

An optical fiber Bragg grating force sensor for monitoring sub-bandage pressure during compression therapy.

Wang DH, Blenman N, Maunder S, Patton V, Arkwright J.

Opt Express. 2013 Aug 26;21(17):19799-807. doi: 10.1364/OE.21.019799.

PMID:
24105528
20.

Low-resolution colonic manometry leads to a gross misinterpretation of the frequency and polarity of propagating sequences: Initial results from fiber-optic high-resolution manometry studies.

Dinning PG, Wiklendt L, Gibbins I, Patton V, Bampton P, Lubowski DZ, Cook IJ, Arkwright JW.

Neurogastroenterol Motil. 2013 Oct;25(10):e640-9. doi: 10.1111/nmo.12170. Epub 2013 Jun 17.

PMID:
23773787
21.

The effect of sacral nerve stimulation on distal colonic motility in patients with faecal incontinence.

Patton V, Wiklendt L, Arkwright JW, Lubowski DZ, Dinning PG.

Br J Surg. 2013 Jun;100(7):959-68. doi: 10.1002/bjs.9114. Epub 2013 Mar 27.

PMID:
23536312
22.

The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia.

Casolaro A, Golay J, Albanese C, Ceruti R, Patton V, Cribioli S, Pezzoni A, Losa M, Texido G, Giussani U, Marchesi F, Amboldi N, Valsasina B, Bungaro S, Cazzaniga G, Rambaldi A, Introna M, Pesenti E, Alzani R.

PLoS One. 2013;8(3):e58424. doi: 10.1371/journal.pone.0058424. Epub 2013 Mar 8.

23.

Pancolonic motor response to subsensory and suprasensory sacral nerve stimulation in patients with slow-transit constipation.

Dinning PG, Hunt LM, Arkwright JW, Patton V, Szczesniak MM, Wiklendt L, Davidson JB, Lubowski DZ, Cook IJ.

Br J Surg. 2012 Jul;99(7):1002-10. doi: 10.1002/bjs.8760. Epub 2012 May 3.

PMID:
22556131
24.

Phosphorylation of TCTP as a marker for polo-like kinase-1 activity in vivo.

Cucchi U, Gianellini LM, De Ponti A, Sola F, Alzani R, Patton V, Pezzoni A, Troiani S, Saccardo MB, Rizzi S, Giorgini ML, Cappella P, Beria I, Valsasina B.

Anticancer Res. 2010 Dec;30(12):4973-85.

PMID:
21187478
25.

Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy.

Albanese C, Alzani R, Amboldi N, Avanzi N, Ballinari D, Brasca MG, Festuccia C, Fiorentini F, Locatelli G, Pastori W, Patton V, Roletto F, Colotta F, Galvani A, Isacchi A, Moll J, Pesenti E, Mercurio C, Ciomei M.

Mol Cancer Ther. 2010 Aug;9(8):2243-54. doi: 10.1158/1535-7163.MCT-10-0190. Epub 2010 Aug 3.

26.

Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging.

Degrassi A, Russo M, Nanni C, Patton V, Alzani R, Giusti AM, Fanti S, Ciomei M, Pesenti E, Texido G.

Mol Cancer Ther. 2010 Mar;9(3):673-81. doi: 10.1158/1535-7163.MCT-09-0726. Epub 2010 Mar 2.

27.

Therapeutic efficacy of the pan-cdk inhibitor PHA-793887 in vitro and in vivo in engraftment and high-burden leukemia models.

Alzani R, Pedrini O, Albanese C, Ceruti R, Casolaro A, Patton V, Colotta F, Rambaldi A, Introna M, Pesenti E, Ciomei M, Golay J.

Exp Hematol. 2010 Apr;38(4):259-269.e2. doi: 10.1016/j.exphem.2010.02.004. Epub 2010 Feb 16.

PMID:
20167248
28.

Diagnostic exercise: sudden death in a mouse with experimentally induced acute myeloid leukemia.

Radaelli E, Marchesi F, Patton V, Scanziani E.

Vet Pathol. 2009 Nov;46(6):1301-5. doi: 10.1354/vp.09-VP-0016-R-DEX. Epub 2009 Jul 15.

PMID:
19605917
29.

Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.

Radaelli E, Ceruti R, Patton V, Russo M, Degrassi A, Croci V, Caprera F, Stortini G, Scanziani E, Pesenti E, Alzani R.

Histol Histopathol. 2009 Jul;24(7):879-91. doi: 10.14670/HH-24.879.

30.

Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate.

Chiesa G, Rigamonti E, Lovati MR, Disconzi E, Soldati S, Sacco MG, Catò EM, Patton V, Scanziani E, Vezzoni P, Arnoldi A, Locati D, Sirtori CR.

Mol Nutr Food Res. 2008 Oct;52(10):1121-9. doi: 10.1002/mnfr.200700296.

PMID:
18655005
31.

A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.

Montagnoli A, Valsasina B, Croci V, Menichincheri M, Rainoldi S, Marchesi V, Tibolla M, Tenca P, Brotherton D, Albanese C, Patton V, Alzani R, Ciavolella A, Sola F, Molinari A, Volpi D, Avanzi N, Fiorentini F, Cattoni M, Healy S, Ballinari D, Pesenti E, Isacchi A, Moll J, Bensimon A, Vanotti E, Santocanale C.

Nat Chem Biol. 2008 Jun;4(6):357-65. doi: 10.1038/nchembio.90. Epub 2008 May 11.

PMID:
18469809
32.

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer.

Carpinelli P, Ceruti R, Giorgini ML, Cappella P, Gianellini L, Croci V, Degrassi A, Texido G, Rocchetti M, Vianello P, Rusconi L, Storici P, Zugnoni P, Arrigoni C, Soncini C, Alli C, Patton V, Marsiglio A, Ballinari D, Pesenti E, Fancelli D, Moll J.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3158-68.

33.

Cytokeratin and vimentin expression in normal and neoplastic canine prostate.

Grieco V, Patton V, Romussi S, Finazzi M.

J Comp Pathol. 2003 Jul;129(1):78-84.

PMID:
12859911
34.
35.

A study of the validity of the Hospital Activity Analysis information.

Martini CJ, Hughes AO, Patton VA.

Br J Prev Soc Med. 1976 Sep;30(3):180-6.

36.

[Anatomo-pathology and study of lipids in Hurler's and Sanfilippo's mucopolysaccharidosis].

Dekaban AS, Patton VM.

Nouv Presse Med. 1973 Feb 17;2(7):415-7. French. No abstract available.

PMID:
4265855
37.

Structural and biochemical maturation of the cerebral pallium in rabbit fetuses: morphogenesis and lipids.

Dekaban AS, Patton VM, Cain DF.

J Neurochem. 1971 Dec;18(12):2451-9. No abstract available.

PMID:
5135905
38.

Gm1-gangliosidosis and juvenile cerebral lipidosis. Clinical, histochemical, and chemical study.

Patton VM, Dekaban AS.

Arch Neurol. 1971 Jun;24(6):529-37. No abstract available.

PMID:
5089899
39.

Hurler's and Sanfilippo's variants of mucopolysaccharidosis. Cerebral pathology and lipid chemistry.

Dekaban AS, Patton VM.

Arch Pathol. 1971 May;91(5):434-43. No abstract available.

PMID:
4252992
40.

Iminoglycinuria--a "harmless" inborn error of metabolism?

Fraser GR, Friedmann AI, Patton VM, Wade DN, Woolf LI.

Humangenetik. 1968;6(4):362-7. No abstract available.

PMID:
5713621
41.

Design of a modern meat-packing waste treatment plant.

Willoughby E, Patton VD.

J Water Pollut Control Fed. 1968 Jan;40(1):132-7. No abstract available.

PMID:
5636892
42.

Spontaneous rupture of the spleen; its occurrence in a patient with situs inversus.

HARBISON SP, PATTON VG, MOYER JF Jr.

Ann Surg. 1954 Feb;139(2):248-9. No abstract available.

Supplemental Content

Loading ...
Support Center